Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 8/20 | 1.00 |
| ▸ | RECQL | P46063 | 4/20 | 1.00 |
| ▸ | STK17B | O94768 | 3/20 | 1.00 |
| ▸ | MAOA | P21397 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | AURKA | O14965 | 2/20 | 1.00 |
| ▸ | GSK3B | P49841 | 2/20 | 1.00 |
| ▸ | CDK5 | Q00535 | 2/20 | 1.00 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 1.00 |
| ▸ | PSMD14 | O00487 | 1/20 | 1.00 |
| ▸ | DAPK3 | O43293 | 1/20 | 1.00 |
| ▸ | JAK2 | O60674 | 1/20 | 1.00 |
| ▸ | ALPL | P05186 | 1/20 | 1.00 |
| ▸ | ALPI | P09923 | 1/20 | 1.00 |
| ▸ | ALPG | P10696 | 1/20 | 1.00 |
| ▸ | CDK4 | P11802 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuretin SCHEMBL30214394 | 1.00 | MEN1 (1.00) | MEN1KMT2ARECQLSTK17BMAOA | |
| Sulfuretin SCHEMBL30214408 | 1.00 | MEN1 (1.00) | MEN1KMT2ARECQLSTK17BMAOA | |
| Sulfuretin SCHEMBL8346701 | 1.00 | MEN1 (1.00) | MEN1KMT2ARECQLSTK17BMAOA | |
| Sulfuretin SCHEMBL634006 | 1.00 | MEN1 (1.00) | MEN1KMT2ARECQLSTK17BMAOA | |
| Sulfuretin SCHEMBL29545005 | 1.00 | MEN1 (1.00) | MEN1KMT2ARECQLSTK17BMAOA | |
| SCHEMBL30337058 | 0.89 | STK17B (1.00) | MEN1KMT2ARECQLSTK17BMAOA | |
| SCHEMBL5707753 | 0.88 | TYR (1.00) | MEN1KMT2ARECQLSTK17BMAOA | |
| SCHEMBL29435856 | 0.88 | TYR (1.00) | MEN1KMT2ARECQLSTK17BMAOA | |
| SCHEMBL30214422 | 0.88 | TYR (1.00) | MEN1KMT2ARECQLSTK17BMAOA | |
| SCHEMBL6964950 | 0.88 | MEN1 (0.78) | MEN1KMT2ARECQLSTK17BMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250009655-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC | 2025-01-09 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2021042001-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| US-12390418-B2 | Biphasic compositions comprising one or both of carbonate and phosphate | Natural Extraction Systems, LLC (US) | 2025-08-19 | — | — | US | disclosed |
| US-20250009655-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC | 2025-01-09 | — | — | US | disclosed |
| CN-116023358-B | Method for extracting genistein, fisetin and thioflavin from cotinus coggygria | 四川太时生物科技集团有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-116023358-A | Method for extracting genistein, fisetin and thioflavin from cotinus coggygria | 四川太时生物科技集团有限公司 | 2023-04-28 | — | — | CN | disclosed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | disclosed |
| CN-115677635-A | Aurone derivative and application thereof | 中国科学院新疆理化技术研究所 | 2023-02-03 | — | — | CN | disclosed |
| WO-2021042001-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | disclosed |
| EP-1888174-B1 | USE OF CHALCONES FOR THE TREATMENT OF VIRAL DISORDERS | JOHNSON & JOHNSON CONSUMER (US) | 2012-02-22 | — | — | EP | disclosed |
| US-7629006-B2 | Process for preparing extract from rhus verniciflua and pharmaceutical composition containing the same | AZI Company, Ltd (KR) | 2009-12-08 | — | — | US | disclosed |
| US-7629006-B2 | Process for preparing extract from rhus verniciflua and pharmaceutical composition containing the same | AZI Company, Ltd (KR) | 2009-12-08 | — | — | US | disclosed |
| US-20080233223-A1 | Process For Preparing Extract From Rhus Verniciflua and Pharmaceutical Composition Containing the Same | AZI CO., LTD. (KR) | 2008-09-25 | — | — | US | disclosed |
| US-20080233223-A1 | Process For Preparing Extract From Rhus Verniciflua and Pharmaceutical Composition Containing the Same | AZI CO., LTD. (KR) | 2008-09-25 | — | — | US | disclosed |
| US-20060270614-A1 | Use of chalcones for the treatment of viral disorders | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2006-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060270614-A1 | Use of chalcones for the treatment of viral disorders | HAVCR2, HMGB3, EIF2AK2 | MEN1 3326/4885KMT2A 4014/4885RECQL 114/4885 |
| US-20080233223-A1 | Process For Preparing Extract From Rhus Verniciflua and Pharmaceutical Composition Containing the Same | CMA1, HRH2, DCXR | MEN1 4880/4885KMT2A 512/4885RECQL 3250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.